- About
- Projects
- Research
- Advancing FDA Mechanisms to Address Complex Cross-Sectoral Health Threats
- Addressing Unmet Need Within the Animal and Veterinary Industries
- Antimicrobial Use Data in Food Animals
- Expanded Access Navigator
- Fellowship
- Food & Nutrition
- FDA Operational Evaluation
- FDA Patient Listening Sessions
- Improving Access to Publicly Available FDA Information
- Improving Understanding of the FDA and FDA-Regulated Products
- Substance Use Disorders
- COVID-19 Hub
- Regulatory Science Accelerator
- News and Events
- eRequest
Coverage
On November 16, 2023, the Reagan-Udall Foundation for the FDA hosted a virtual meeting to outline the proposed label changes. These new markings intend to help consumers quickly identify the details of food packaging; it should be especially helpful for…
On Wednesday, the FDA’s Center for Veterinary Medicine announced that it is supporting a collaborative agreement to the Reagan-Udall Foundation for the FDA to conduct a strengths, weaknesses, opportunities, and threats (SWOT) analysis.
As the U.S. Food and Drug Administration’s Center for Veterinary Medicine continues to progress in implementation of its Animal and Veterinary Innovation Agenda, the center is supporting a collaborative agreement to the Reagan-Udall Foundation for the…
In a continuation of progress towards the implementation of the AVIA, the FDA announced support for a collaboration agreement to the Reagan-Udall Foundation for the FDA.
The event was hosted by the Reagan-Udall Foundation for the FDA. While it didn’t center on psychedelic-assisted treatments only, many exchanged views on the topic.
Read more
In Silico Methods drive scientific innovation by leveraging computer simulation instead of biological testing.
Read more
Last Friday, the Reagan-Udall Foundation held a public meeting to discuss the advancement of treatments for PTSD, which includes psychedelics.
A new report from the Reagan-Udall Foundation for the FDA explores which parts of the rule are confusing to executives that are working to bring their companies into alignment with the rule.
New labels would inform consumer whether the products are high in added sugars, sodium or saturated fats.
The press conference followed the FDA and Reagan-Udall Foundation's public meeting on PTSD, which included discussions on psychedelic therapy.
Read more